77 related articles for article (PubMed ID: 23526412)
1. Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study.
Luostarinen T; Namujju PB; Merikukka M; Dillner J; Hakulinen T; Koskela P; Paavonen J; Surcel HM; Lehtinen M
Int J Cancer; 2013 Oct; 133(7):1756-9. PubMed ID: 23526412
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
Safaeian M; Quint K; Schiffman M; Rodriguez AC; Wacholder S; Herrero R; Hildesheim A; Viscidi RP; Quint W; Burk RD
J Natl Cancer Inst; 2010 Dec; 102(23):1794-804. PubMed ID: 21098758
[TBL] [Abstract][Full Text] [Related]
3. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
Int J Cancer; 1999 Mar; 80(6):818-22. PubMed ID: 10074912
[TBL] [Abstract][Full Text] [Related]
4. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri.
Luostarinen T; Lehtinen M; Bjørge T; Abeler V; Hakama M; Hallmans G; Jellum E; Koskela P; Lenner P; Lie AK; Paavonen J; Pukkala E; Saikku P; Sigstad E; Thoresen S; Youngman LD; Dillner J; Hakulinen T
Eur J Cancer; 2004 May; 40(7):1058-65. PubMed ID: 15093583
[TBL] [Abstract][Full Text] [Related]
5. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil.
da Silva Barros NK; Costa MC; Alves RR; Villa LL; Derchain SF; Zeferino LC; Dos Santos Carneiro MA; Rabelo-Santos SH
J Med Virol; 2012 Jul; 84(7):1143-50. PubMed ID: 22585734
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.
Naucler P; Chen HC; Persson K; You SL; Hsieh CY; Sun CA; Dillner J; Chen CJ
J Gen Virol; 2007 Mar; 88(Pt 3):814-822. PubMed ID: 17325353
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
Roura E; Travier N; Waterboer T; de Sanjosé S; Bosch FX; Pawlita M; Pala V; Weiderpass E; Margall N; Dillner J; Gram IT; Tjønneland A; Munk C; Palli D; Khaw KT; Overvad K; Clavel-Chapelon F; Mesrine S; Fournier A; Fortner RT; Ose J; Steffen A; Trichopoulou A; Lagiou P; Orfanos P; Masala G; Tumino R; Sacerdote C; Polidoro S; Mattiello A; Lund E; Peeters PH; Bueno-de-Mesquita HB; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Lindquist D; Idahl A; Travis RC; Merritt MA; Gunter MJ; Rinaldi S; Tommasino M; Franceschi S; Riboli E; Castellsagué X
PLoS One; 2016; 11(1):e0147029. PubMed ID: 26808155
[TBL] [Abstract][Full Text] [Related]
8. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
Madeleine MM; Anttila T; Schwartz SM; Saikku P; Leinonen M; Carter JJ; Wurscher M; Johnson LG; Galloway DA; Daling JR
Int J Cancer; 2007 Feb; 120(3):650-5. PubMed ID: 17096345
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
Koskela P; Anttila T; Bjørge T; Brunsvig A; Dillner J; Hakama M; Hakulinen T; Jellum E; Lehtinen M; Lenner P; Luostarinen T; Pukkala E; Saikku P; Thoresen S; Youngman L; Paavonen J
Int J Cancer; 2000 Jan; 85(1):35-9. PubMed ID: 10585579
[TBL] [Abstract][Full Text] [Related]
10. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries).
Hakama M; Luostarinen T; Hallmans G; Jellum E; Koskela P; Lehtinen M; Thoresen S; Youngman L; Hakulinen T
Cancer Causes Control; 2000 Oct; 11(9):783-90. PubMed ID: 11075866
[TBL] [Abstract][Full Text] [Related]
11. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor.
Simonetti AC; Melo JH; de Souza PR; Bruneska D; de Lima Filho JL
Microbes Infect; 2009 Apr; 11(4):435-42. PubMed ID: 19397882
[TBL] [Abstract][Full Text] [Related]
12. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.
Vriend HJ; Bogaards JA; van Bergen JE; Brink AA; van den Broek IV; Hoebe CJ; King AJ; van der Sande MA; Wolffs PF; de Melker HE;
Cancer Med; 2015 Oct; 4(10):1589-98. PubMed ID: 26194784
[TBL] [Abstract][Full Text] [Related]
13. Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort.
Castellsagué X; Pawlita M; Roura E; Margall N; Waterboer T; Bosch FX; de Sanjosé S; Gonzalez CA; Dillner J; Gram IT; Tjønneland A; Munk C; Pala V; Palli D; Khaw KT; Barnabas RV; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Fagherazzi G; Kaaks R; Lukanova A; Steffen A; Trichopoulou A; Trichopoulos D; Klinaki E; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Lund E; Weiderpass E; Quirós JR; Sánchez MJ; Navarro C; Barricarte A; Larrañaga N; Ekström J; Hortlund M; Lindquist D; Wareham N; Travis RC; Rinaldi S; Tommasino M; Franceschi S; Riboli E
Int J Cancer; 2014 Jul; 135(2):440-52. PubMed ID: 24338606
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
Smith JS; Muñoz N; Herrero R; Eluf-Neto J; Ngelangel C; Franceschi S; Bosch FX; Walboomers JM; Peeling RW
J Infect Dis; 2002 Feb; 185(3):324-31. PubMed ID: 11807714
[TBL] [Abstract][Full Text] [Related]
15. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.
Arnheim Dahlström L; Andersson K; Luostarinen T; Thoresen S; Ögmundsdottír H; Tryggvadottír L; Wiklund F; Skare GB; Eklund C; Sjölin K; Jellum E; Koskela P; Wadell G; Lehtinen M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2541-50. PubMed ID: 21994401
[TBL] [Abstract][Full Text] [Related]
16. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents.
Samoff E; Koumans EH; Markowitz LE; Sternberg M; Sawyer MK; Swan D; Papp JR; Black CM; Unger ER
Am J Epidemiol; 2005 Oct; 162(7):668-75. PubMed ID: 16120706
[TBL] [Abstract][Full Text] [Related]
17. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
Wallin KL; Wiklund F; Luostarinen T; Angström T; Anttila T; Bergman F; Hallmans G; Ikäheimo I; Koskela P; Lehtinen M; Stendahl U; Paavonen J; Dillner J
Int J Cancer; 2002 Oct; 101(4):371-4. PubMed ID: 12209962
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis.
Zhu H; Shen Z; Luo H; Zhang W; Zhu X
Medicine (Baltimore); 2016 Mar; 95(13):e3077. PubMed ID: 27043670
[TBL] [Abstract][Full Text] [Related]
19. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Sutcliffe S; Giovannucci E; Gaydos CA; Viscidi RP; Jenkins FJ; Zenilman JM; Jacobson LP; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1573-80. PubMed ID: 17684131
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix.
Fehér E; Szalmás A
Acta Microbiol Immunol Hung; 2006 Dec; 53(4):479-87. PubMed ID: 17278714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
